The GATRA is a program whose aim is to identify and support innovative clinical and scientific research aimed at gaining more insight into the current and new uses of Antithrombin.
By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care
Applications for the GATRA Award 2022 will be accepted between 01/11/2021 and 30/04/2022.
Please click here to apply.
To see the 2021 GATRA Award winner please click here.